Ex-OpenAI Talent Builds $3.8B AI Drug Discovery Startup Chai Discovery
rishabh16_ · x · 2026-08-05
Josh Meier, co-founder & CEO of Chai Discovery, shared his vision in an interview. After training LLMs at OpenAI and building the first protein transformer at Meta, he now leads Chai Discovery. The 2-year-old, 30-person company, valued at $3.8B, focuses on AI drug design for clients like Eli Lilly, Pfizer, and Novartis. He views AI's potential to cure complex diseases as the greatest argument for rapid development and a moral obligation.
More from Companies & People
- Google AI Pillars Jeff Dean, Sanjay Ghemawat Depart to Found Discovery Loop — dustinvtran · 2026-08-06
- DeepMind and Google AI Legends Branch Out: Demis to Health, Jeff Dean to Startup — TheTuringPost · 2026-08-06
- Cohere CEO Jokes: Time to Bring Back Google Brain — aidangomez · 2026-08-06
- Dev Slams Google's AI Progress: No Breakthroughs Since 2017 Transformer — MarcJSchmidt · 2026-08-06
- Jeff Dean's Departure and Google's Investment Deemed 'Massively Bullish' for Google — shakoistsLog · 2026-08-06
- Google's Top AI Brains Depart to Launch Startup Discovery Loop — Rare_Bunch4348 · 2026-08-06